Waitlist-controlled Trial of a Psychological Education Program for Nurses
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01593683|
Recruitment Status : Unknown
Verified July 2013 by William Pirl, Massachusetts General Hospital.
Recruitment status was: Active, not recruiting
First Posted : May 8, 2012
Last Update Posted : July 10, 2013
|Condition or disease||Intervention/treatment||Phase|
|Psychological Stress||Behavioral: Psychological education program for nurses||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||42 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||Waitlist-controlled Trial of a Psychological Education Program for Nurses|
|Study Start Date :||March 2012|
|Actual Primary Completion Date :||January 2013|
|Estimated Study Completion Date :||September 2013|
Experimental: Psychological education program
Patients receive the psychological education program upon study enrollment.
Behavioral: Psychological education program for nurses
Approximately 4 weekly one-hour group sessions led by study clinicians and 1 optional individual session with a single study clinician.
No Intervention: Waitlist
Participants are assigned to a 16-week wait-list period upon enrollment. Participants are invited to receive the psychological education program following the waitlist period.
- Change from baseline in psychological stress as measured by the Perceived Stress Scale and the Maslach Burnout Inventory [ Time Frame: At approximately 16 and 32 weeks post-baseline ]
- Change in from baseline in medical errors as measured by the Medical Errors Questionnaire [ Time Frame: At approximately 16 and 32 weeks post-baseline ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01593683
|United States, Massachusetts|
|Massachusetts General Hospital|
|Boston, Massachusetts, United States, 02114|
|Principal Investigator:||William F Pirl, MD, MPH||Massachusetts General Hospital|